FGF-2 export and deposition in the endosteal niche appear to be one of the main contributors to the maintenance of dormancy in ER+ breast cancer cells, and the loss of this function in aging MSCs contributes significantly to the observed stochastic recurrence of bone marrow micrometastases. Here, FGF2 is linked to breast carcinoma.